News releases
Showing 1 - 10 of 10 results
October 24, 2024
The unique needs of the pediatric population require specialized solutions,” said Sarah Herrmann, Vizient director of program services. read more
August 20, 2024
Vizient, Inc. offered comments to the Food and Drug Administration on biosimilar interchangeability. read more
April 23, 2024
The inaugural symposium brought together leading healthcare providers, payers and manufacturers of high-cost, ultra-specialty pharmaceuticals to discuss the promise the rapidly expanding market of ce... read more
August 23, 2023
A Vizient white paper demonstrates how the lack of information about medication access across the supply chain is exacerbating the shortage of seven oncology drugs used to treat a multitude of cancer... read more
January 26, 2023
Vizient, Inc. released its Winter 2023 Pharmacy Market Outlook, forecasting a 3.78% overall drug price inflation rate for the calendar year beginning, July 1, 2023. read more
August 23, 2022
The survey of hospital leaders and pharmacy professionals from Vizient member hospitals across the country found that biosimilars are gaining inclusion in hospital formularies, something long seen as... read more
July 28, 2022
COVID-19 drug remdesivir slips to No. 2 spot in total Vizient member spend Vizient, Inc. released its Summer 2022 Pharmacy Market Outlook forecasting a 3.26% overall drug price inflation rate for th... read more
January 26, 2022
The finding is reported in the Vizient Winter 2022 Pharmacy Market Outlook, which forecasts an overall 3.09% increase in drug prices for July 1, 2022 through June 30, 2023. read more
August 30, 2021
Vizient released an analysis which estimates U.S. hospitals are spending $310 million annually to manage additional work of white and brown bagging. read more
November 23, 2020
Vizient releases updated analysis showing ending the FDA's Unapproved Drugs Initiative could save hospitals between $7.52 billion and $26.59 billion. read more